Hey Winston, are these BIG CATALYSTS the same ones you
Hey Winston, are these BIG CATALYSTS the same ones you expected to see in November? Are these the same ones or different ones? If they are the same catalysts you expected in November, does it make it more likely to happen in Dec/Jan - since they didn't happen, yet? Or, less likely because something came up.
If they are not the same BIG CATALYSTS we expected to see in November, are they indeed new ones that could be delayed because things always take more time than we hope/expect.
The courtesy of a response would be appreciated. Thanks.
On4 Communications (ONCI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
New Collaboration Between Philips and Masimo In a significant development in the healthcare technology sector, Royal Philips and Masimo have announced an exciting renewal of their collaboration. This renewed partnership reflects the ongoing commitment of both companies towards innovation and improving the experiences of patients and healthcare providers alike. Advancing...
Continue Reading
Cava Group's Unusual Options Activity Overview Investors looking to capitalize on market trends have adopted a bullish outlook on Cava Group (CAVA). This significant move is invaluable information for retail traders. Today, we observed noteworthy activity in the options market which has been reported on various trading platforms. Such trades suggest that knowledgeable...
Continue Reading
MDU Resources Announces Quarterly Dividend Update Today, MDU Resources Group, Inc. (NYSE: MDU) has declared a quarterly dividend of 13 cents per share on its common stock, continuing its commitment to return value to its shareholders. This dividend remains unchanged from the previous quarter, reflecting the company’s stable financial position and its confidence in...
Continue Reading
JCDecaux's Q3 2024 Business Insights On November 7, JCDecaux SE (Euronext Paris: DEC), recognized as the leading outdoor advertising firm globally, released its comprehensive report for Q3 2024, highlighting developments up to September 30, 2024. Year-Over-Year Performance During this quarter, JCDecaux reported a remarkable revenue increase of 10.9%, reaching a total of...
Continue Reading
Exciting Collaboration Between Zealand Pharma and Roche Zealand Pharma A/S has reached a significant milestone by finalizing its collaboration and license agreement with Roche, a move widely anticipated in the biotechnology sector. The partnership marks a turning point in Zealand Pharma's mission to be a leader in innovative peptide-based therapies, especially in the...
Continue Reading
